2m 2m 2m 2m 2m 2m 2m
TANDEM DIABETES (TNDM)
NASDAQ
$18.43-$0.17 (-0.90%)
Price as of Jun 03, 2026 7:34 PM EDT- $1.2BMarket Cap
- -9.84%1-Year Change
- Medical DevicesIndustry
TANDEM DIABETES (TNDM)
$18.43-$0.17 (-0.90%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.0B +7.93% | 940.2M +25.74% | 747.7M -6.68% | 801.2M +14.00% | |
Cost of Revenue | 468.7M +4.02% | 450.6M +18.58% | 380.0M -2.11% | 388.2M +18.88% | |
Gross Profit | 546.0M +11.53% | 489.6M +33.15% | 367.7M -10.97% | 413.0M +9.77% | |
Sales and Marketing Expense | 445.0M +14.15% | 389.8M +10.59% | 352.5M +5.01% | 335.7M +28.36% | |
Research and Development Expense | -193.1M -2.90% | -198.9M +17.22% | -169.7M -0.29% | -170.2M +84.84% | |
Depreciation and Amortization Expense | 17.7M +6.38% | 16.6M +5.68% | 15.7M +9.67% | 14.3M +3.50% | |
Total Operating Expenses | 733.3M +24.56% | 588.7M -2.03% | 600.9M +18.80% | 505.8M +43.07% | |
Operating Profit | -187.3M +88.91% | -99.1M -57.50% | -233.2M +151.20% | -92.8M -509.87% | |
Interest Income | N/A N/A | 18.0M -21.28% | 22.9M +277.38% | 6.1M +798.66% | |
Interest Expense | -6.8M -3.66% | -7.1M -28.49% | -9.9M +59.18% | -6.2M +2.78% | |
Interest Income and Expense and Net | -6.8M -162.31% | 10.9M -15.80% | 13.0M +8,693.38% | -151,000 -97.19% | |
Total Nonoperating Income and Expense | -13.0M -279.34% | 7.3M -44.07% | 13.0M +324,500.00% | -4,000 -99.94% | |
Income before Taxes | -200.3M +117.99% | -91.9M -58.29% | -220.3M +137.21% | -92.9M -683.94% | |
Income Taxes | 4.4M +6.81% | 4.2M +76.28% | 2.4M +35.30% | 1.7M +420.00% | |
Extraordinary Items | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Net Income | -204.7M +113.18% | -96.0M -56.86% | -222.6M +135.33% | -94.6M -707.70% | |
Net Income from Continuing Operations Applicable to Common | -200.3M +117.99% | -91.9M -58.29% | -220.3M +137.21% | -92.9M -683.94% | |
Basic EPS and Net Income | -3.04 +106.80% | -1.47 -57.14% | -3.43 +133.33% | -1.47 -688.00% | |
Diluted EPS and Net Income | -3.04 +106.80% | -1.47 -57.14% | -3.43 +133.33% | -1.47 -712.50% | |
Basic Weighted Average Shares | 67.3M +2.80% | 65.5M +0.74% | 65.0M +1.28% | 64.1M +1.82% | |
Diluted Weighted Average Shares | 67.3M +2.80% | 65.5M +0.74% | 65.0M +1.28% | 64.1M -0.32% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 90.6M +30.91% | 69.2M +17.61% | 58.9M -65.88% | 172.5M +142.36% | |
Short-Term Investments | 202.0M -45.26% | 369.1M -9.77% | 409.0M -7.95% | 444.4M -19.59% | |
Cash and Cash Equivalents and Short-Term Investments | 292.7M -33.23% | 438.3M -6.32% | 467.9M -24.15% | 616.9M -1.11% | |
Total Current Assets | 618.1M -14.68% | 724.5M -3.14% | 748.0M -12.00% | 850.0M +4.74% | |
Accumulated Depreciation | 73.0M +16.27% | 62.8M +19.01% | 52.8M -6.02% | 56.2M +14.25% | |
Property and Plant and Equipment and Net | 83.6M +6.95% | 78.2M +2.10% | 76.5M +11.66% | 68.6M +36.05% | |
Total Long-Term Assets | 22.9M +342.62% | 5.2M -87.19% | 40.3M +70.69% | 23.6M +50.25% | |
Total Assets | 881.1M -8.94% | 967.7M +1.57% | 952.7M -9.51% | 1.1B +16.31% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 0 -100.00% | 40.7M N/A | N/A N/A | 0 N/A | |
Total Current Liabilities | 242.7M -1.75% | 247.0M +26.52% | 195.3M +18.13% | 165.3M +25.36% | |
Total Long-Term Debt | 310.0M +0.57% | 308.3M +8.15% | 285.0M +0.64% | 283.2M +0.63% | |
Total Long-Term Liabilities | 49.7M +53.67% | 32.4M +1.69% | 31.8M +33.08% | 23.9M -31.23% | |
Total Liabilities | 725.9M +3.03% | 704.6M +10.26% | 639.0M +4.27% | 612.8M +29.83% | |
Retained Earnings | -1.3B +19.54% | -1.0B +10.09% | -951.8M +30.53% | -729.2M +14.91% | |
Total Stockholders Equity | 155.2M -41.02% | 263.1M -16.11% | 313.6M -28.71% | 439.9M +1.58% | |
Total Shares Outstanding | 68.3M +3.06% | 66.3M +1.09% | 65.6M +1.61% | 64.5M +1.07% | |
Cash Flow | |||||
Cash from Operating Activities | -9.7M -140.13% | 24.2M +176.16% | -31.8M -163.04% | 50.5M -54.68% | |
Capital Expenditures | 19.9M +3.73% | 19.2M -28.25% | 26.8M -21.39% | 34.1M +140.46% | |
Cash from Investing Activities | 72.9M +410.35% | -23.5M -72.61% | -85.7M -358.50% | 33.2M +117.75% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -43.4M -618.31% | 8.4M +103.43% | 4.1M -75.63% | 16.9M -67.50% | |
Financials Ratio | |||||
Gross Margin | 53.81% +3.34% | 52.07% +5.89% | 49.18% -4.60% | 51.54% -3.71% | |
Operating Margin | -18.45% +75.03% | -10.54% -66.20% | -31.19% +169.17% | -11.59% -459.52% | |
Return on Assets | -22.15% +121.43% | -10.00% -54.95% | -22.20% +129.76% | -9.66% -603.29% | |
Return on Equity | -97.88% +193.95% | -33.30% -43.64% | -59.08% +172.64% | -21.67% -656.44% | |
Revenue Growth | 7.93% -69.21% | 25.74% +485.54% | -6.68% -147.68% | 14.00% -65.75% | |
Current Ratio | 2.55 -13.16% | 2.93 -23.45% | 3.83 -25.50% | 5.14 -16.45% | |
Cash Ratio | 0.37 +33.26% | 0.28 -7.06% | 0.30 -71.11% | 1.04 +93.35% | |
Debt-to-Equity Ratio | 2.00 +50.64% | 1.33 N/A | N/A N/A | 0.64 N/A | |
Debt-to-Assets Ratio | 0.35 -2.41% | 0.36 N/A | N/A N/A | 0.27 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow